Overview
RhBMP-2 in Intrabony Defects - A Randomized Controlled Trial
Status:
Completed
Completed
Trial end date:
2019-10-11
2019-10-11
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study evaluated the regenerative potential of rhBMP-2 gel in intrabony defects when compared to sticky bone (control).Phase:
Phase 2Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
SVS Institute of Dental Sciences
Criteria
Inclusion Criteria:- Systemically healthy male and female patients age 20-55 years with intrabony defects
and probing pocket depth of ≥5mm after initial therapy were included in the study.
Exclusion Criteria:
- Medically compromised patients, Subjects who underwent radiotherapy or chemotherapy
and smokers were excluded.